(0.09%) 5 521.75 points
(0.12%) 39 892 points
(0.20%) 19 790 points
(-0.01%) $81.62
(0.60%) $2.83
(-0.28%) $2 337.80
(0.17%) $29.58
(0.27%) $1 004.50
(0.02%) $0.932
(-0.08%) $10.53
(0.00%) $0.788
(-2.06%) $86.18
3.79% $ 15.88
Live Chart Being Loaded With Signals
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 1.82M |
Średni wolumen | 1.64M |
Kapitalizacja rynkowa | 2.62B |
EPS | $0.100 ( Q1 | 2024-05-09 ) |
Następna data zysków | ( $0 ) 2024-07-31 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-42.92 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0160 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-08 | Schneyer Mark C. | Buy | 1 893 | Common Stock |
2024-06-10 | Schneyer Mark C. | Sell | 975 | Common Stock |
2024-06-08 | Schneyer Mark C. | Sell | 1 893 | Restricted Stock Units |
2024-05-29 | Ndu Adora | Buy | 15 959 | Director Stock Options (Right to Buy) |
2024-05-29 | Ndu Adora | Buy | 6 652 | Common Stock |
INSIDER POWER |
---|
60.99 |
Last 98 transactions |
Buy: 1 133 433 | Sell: 272 974 |
Wolumen Korelacja
ACADIA Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
QNRX | 0.98 |
PRTS | 0.972 |
LPSN | 0.971 |
TTEC | 0.971 |
UONE | 0.97 |
APTO | 0.969 |
UONEK | 0.968 |
BCAN | 0.965 |
SVC | 0.965 |
DMTK | 0.964 |
10 Najbardziej negatywne korelacje | |
---|---|
OZEM | -1 |
ARYD | -0.973 |
RNA | -0.972 |
CRAI | -0.964 |
PNTG | -0.962 |
DAVE | -0.961 |
ESTA | -0.959 |
GHRS | -0.959 |
SHLD | -0.956 |
NTRA | -0.954 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ACADIA Pharmaceuticals Korelacja - Waluta/Towar
ACADIA Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $726.44M |
Zysk brutto: | $680.71M (93.70 %) |
EPS: | $-0.370 |
FY | 2023 |
Przychody: | $726.44M |
Zysk brutto: | $680.71M (93.70 %) |
EPS: | $-0.370 |
FY | 2022 |
Przychody: | $517.24M |
Zysk brutto: | $507.07M (98.03 %) |
EPS: | $-1.340 |
FY | 2021 |
Przychody: | $484.15M |
Zysk brutto: | $465.00M (96.05 %) |
EPS: | $-1.067 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej